Dudediligence.

Entrada Therapeutics, Inc

TRDANASDAQ · Pharmaceutical Preparations
Write an idea

Insiders

Last 12 months

Sales planned on beside the trades reported on , and whether each names a .

Planned ·

$5,126,906

9 notices · 622,948 sh

Oct 2025 to Oct 2026

Reported ·

$15.1M

44 sales · 17 buys · $1,643,402 bought

Oct 2025 to Sep 2026

The two figures cover different periods.

9 of 44 reported sales carry the 10b5-1 box. Together they are 4.97% of the shares on issue.

PLANNED · FORM 144Oct 2025 to Oct 2026REPORTED · FORM 4Oct 2025 to Sep 2026N2025DJ2026FMAMJJASO2026-07-30: 5AM Ventures V, L.P., Form 1442026-05-04: NATHAN DOWDEN, Form 1442026-05-04: NATARAJAN SETHURAMAN, Form 1442026-04-01: KORY WENTWORTH, Form 1442026-03-09: KORY WENTWORTH, Form 1442026-03-09: NATHAN DOWDEN, Form 1442026-03-04: KORY WENTWORTH, Form 1442025-11-21: KORY WENTWORTH, Form 1442025-11-14: 5AM Ventures V, L.P., Form 1442025-11-10: BAKER JULIAN, bought2025-11-14: ROCKLAGE SCOTT M, sold2025-11-14: PARMAR KUSH, sold2025-11-20: BAKER JULIAN, bought2025-11-21: WENTWORTH KORY JAMES, sold2026-03-04: WENTWORTH KORY JAMES, sold2026-03-09: WENTWORTH KORY JAMES, sold2026-03-09: Dowden Nathan J, sold2026-04-01: WENTWORTH KORY JAMES, sold2026-05-04: Dowden Nathan J, sold2026-05-04: Sethuraman Natarajan, sold2026-05-20: Zeiher Bernhardt G, bought2026-07-30: ROCKLAGE SCOTT M, sold2026-07-30: PARMAR KUSH, sold2026-08-06: ROCKLAGE SCOTT M, sold2026-08-06: PARMAR KUSH, sold2026-08-24: MPM BIOVENTURES 2018, L.P., sold2026-08-24: GADICKE ANSBERT, sold2026-08-27: GADICKE ANSBERT, sold2026-08-27: MPM BIOVENTURES 2018, L.P., sold2026-09-01: GADICKE ANSBERT, sold2026-09-01: MPM BIOVENTURES 2018, L.P., sold2026-09-04: GADICKE ANSBERT, sold2026-09-04: MPM BIOVENTURES 2018, L.P., sold
under a no plan named▼ sale▲ buysize is dollars

Form 144 notices, newest first

2026-07-305AM Ventures V, L.P., Affiliated stockholder$2,169,072
331,156 shno plan date144 ↗
Form 4, 2026-08-03: sold 116,474 at $6.93 Form 4 ↗
2026-05-04NATHAN DOWDEN, President & COO$217,500
15,000 shplan 2025-03-07144 ↗
Form 4, 2026-05-04: sold 15,000 at $15.33 Form 4 ↗
2026-05-04NATARAJAN SETHURAMAN, President, Research & Develop.$375,652
25,907 shplan 2024-11-18144 ↗
Form 4, 2026-05-04: sold 25,907 at $15.39 Form 4 ↗
2026-04-01KORY WENTWORTH, Chief Financial Officer$31,550
2,500 shplan 2025-03-06144 ↗
Form 4, 2026-04-02: sold 2,500 at $12.95 Form 4 ↗
2026-03-09KORY WENTWORTH, Chief Financial Officer$207,281
16,477 shplan 2025-03-06144 ↗
Form 4, 2026-03-11: sold 16,477 at $13.01 Form 4 ↗
2026-03-09NATHAN DOWDEN, President & COO$188,826
15,010 shplan 2025-03-07144 ↗
Form 4, 2026-03-11: sold 15,010 at $13.04 Form 4 ↗
2026-03-04KORY WENTWORTH, Chief Financial Officer$94,658
7,988 shplan 2025-03-06144 ↗
Form 4, 2026-03-06: sold 7,988 at $12.25 Form 4 ↗
2025-11-21KORY WENTWORTH, Chief Financial Officer$81,705
8,910 shplan 2025-03-06144 ↗
Form 4, 2025-11-24: sold 8,910 at $9.98 Form 4 ↗
2025-11-145AM Ventures V, L.P., Affiliated Stockholder$1,760,664
200,000 shno plan date144 ↗
Form 4, 2025-11-18: sold 200,000 at $8.80 Form 4 ↗